Janux Therapeutics (JANX)
(Real Time Quote from BATS)
$36.68 USD
+1.39 (3.94%)
Updated Aug 8, 2024 01:34 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -0.32 |
EPS Last Quarter | -0.11 |
Last EPS Surprise | 65.63% |
ABR | 1.25 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.34 |
Next Year | -1.63 |
EPS (TTM) | -0.91 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.06M | NA | 2.11M | NA |
# of Estimates | 1 | NA | 3 | NA |
High Estimate | 1.06M | NA | 3.37M | NA |
Low Estimate | 1.06M | NA | 1.25M | NA |
Year ago Sales | 2.52M | 2.46M | 8.08M | 2.11M |
Year over Year Growth Est. | -57.94% | NA | -73.95% | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.32 | -0.34 | -1.34 | -1.63 |
# of Estimates | 3 | 3 | 5 | 4 |
Most Recent Consensus | -0.38 | -0.37 | -1.42 | -1.72 |
High Estimate | -0.23 | -0.23 | -0.97 | -1.00 |
Low Estimate | -0.37 | -0.41 | -1.54 | -2.17 |
Year ago EPS | -0.25 | -0.25 | -1.32 | -1.34 |
Year over Year Growth Est. | -28.00% | -36.00% | -1.52% | -21.53% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.32 | -0.34 | -1.34 | -1.63 |
7 Days Ago | -0.32 | -0.34 | -1.34 | -1.63 |
30 Days Ago | -0.32 | -0.34 | -1.34 | -1.63 |
60 Days Ago | -0.32 | -0.34 | -1.34 | -1.63 |
90 Days Ago | -0.32 | -0.35 | -1.35 | -1.61 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.32 | -0.34 | -1.34 | -1.63 |
Zacks Consensus Estimate | -0.32 | -0.34 | -1.34 | -1.63 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.11 | -0.30 | -0.25 | -0.25 | NA |
Estimate | -0.32 | -0.35 | -0.37 | -0.46 | NA |
Difference | 0.21 | 0.05 | 0.12 | 0.21 | 0.15 |
Surprise | 65.63% | 14.29% | 32.43% | 45.65% | 39.50% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more